Measles in the 21st Century, a Continuing Preventable Risk to Travelers: Data From the GeoSentinel Global Network

• Type of Material: Article
• Authors: Mark J. Sotir, Centers for Disease Control and Prevention; Douglas H. Esposito, Maxwell Finland Laboratory for Infectious Diseases; Elizabeth Barnett, Maxwell Finland Laboratory for Infectious Diseases; Karen Leder, Monash University; Phyllis E Kozarsky, Emory University; Poh L. Lim, Tan Tock Seng Hospital and Lee Kong Chian School of Medicine; Effrossyni Gkrania-Klotsas, University of Cambridge; Davidson H. Hamer, Boston Medical Center; Susan Kuhn, University of Calgary; Bradley A. Connor, Cornell University; Rashila Pradhan, CIWEC Clinic Travel Medicine Center and Hospital; Eric Caumes, University Pierre et Marie Curie
• Language: English
• Date: 2016-01-15
• Publisher: Oxford University Press (OUP)
• Publication Version: Author Accepted Manuscript (After Peer Review)
• Copyright Statement: © 2016, Oxford University Press
• Final Published Version (URL): http://dx.doi.org/10.1093/cid/civ839
• Title of Journal or Parent Work: Clinical Infectious Diseases
• ISSN: 1058-4838
• Volume: 62
• Issue: 2
• Start Page: 210
• End Page: 212
• Grant/Funding Information: Dr. Leder’s institution receives money from GSK, Dr. Leder receives money as payment for lectures including service on speaker’s bureaus from GSK, and Dr. Leder receives money for travel accommodations and meeting expenses unrelated to activities listed from GSK and Sanofi.; Dr. Connor receives money for consultancy with Valneva and Salix Pharamaceuticals, royalties from a textbook published by Elsevier, and payment for development of educational presentations from Lupin Pharmaceuticals.; Dr. Kuhn’s institution receives money from GlaxoSmithKline (GSK) and Sanofi Pasteur.; Dr. Hamer’s institution receives money via the GeoSentinel cooperative agreement and support for travel to meetings for the study of other purposes from ISTM under the GeoSentinel cooperative agreement.; Dr. Gkrania-Klotsas’s institution receives money from a grant with NHR BRC, support for travel for meetings for the study of other purposes from ISTM, and travel accommodations and meeting expenses unrelated to activities listed from GILEAD.; Dr. Barnett’s institution receives money via the GeoSentinel cooperative agreement and royalties from BMJ Point of Care, Elsiver and UptoDate.; GeoSentinel, the Global Surveillance Network of the International Society of Travel Medicine (ISTM), is supported by Cooperative Agreement U50/CCU412347 from the Centers for Disease Control and Prevention (CDC).
• Keywords: travelers; JANUARY; surveillance; Science & Technology; Microbiology; measles; infection; Infectious Diseases; Immunology; GeoSentinel; OUTBREAK; Life Sciences & Biomedicine
• Research Categories: Health Sciences, Public Health; Health Sciences, General; Health Sciences, Epidemiology

Abstract

This work is written by (a) US Government employee(s) and is in the public domain in the US. Measles remains a risk for travelers, with 94 measles diagnoses reported to the GeoSentinel network from 2000 to 2014, two-thirds since 2010. Asia was the most common exposure region, then Africa and Europe. Efforts to reduce travel-associated measles should target all vaccine-eligible travelers, including catch-up vaccination of susceptible adults.